Bisson Jean Marc
About Bisson Jean Marc
Bisson Jean Marc is the Manager Pricing at Bristol-Myers Squibb in Montreal, Quebec, with extensive experience in finance and pricing strategy.
Current Role at Bristol-Myers Squibb
Bisson Jean Marc is currently serving as the Manager Pricing at Bristol-Myers Squibb, based in Montreal, Quebec. In this role, he manages all aspects of list prices including pricing strategy, price setting, and global floors. He also oversees hospital and GPO contracts, addresses audit issues related to Market Access, and handles the resolution of PLA and billing issues with government entities.
Past Roles at Bristol-Myers Squibb
Bisson Jean Marc has held multiple positions at Bristol-Myers Squibb over his career. Prior to his current role, he served as a Project Manager (2010-2011) in St-Laurent, Quebec. Before that, he worked as a Business Analyst (2004-2010) for six years, a Financial Analyst (1998-2004) for another six years, and an Accounting Specialist (1996-1998) for two years. Additionally, he worked as an Accounts Payable Coordinator (1992-1995) for three years at the same location.
Previous Experience at Fiducie Desjardins
Before joining Bristol-Myers Squibb, Bisson Jean Marc worked at Fiducie Desjardins as a Financial Advisor for eight months from 1995 to 1996 in Montreal, Quebec. This role marked an important step early in his career in the financial services industry.
Educational Background at Concordia University
Bisson Jean Marc completed his Bachelor of Commerce (BCom) with a major in Finance and a minor in Marketing from Concordia University. He studied there from 1988 to 1992. This educational grounding has provided him with the foundational knowledge essential for his subsequent roles in finance and pricing.
Expertise in PMPRB Compliance and Reporting
In his current role at Bristol-Myers Squibb, Bisson Jean Marc has demonstrated expertise in PMPRB compliance and reporting. This includes handling HDAP submissions and ensuring full compliance with these regulatory requirements. His skills in this area are critical for maintaining Bristol-Myers Squibb's adherence to pricing regulations and audit standards.